| Dr Robin Kyin, MD | |
|
308 Willow Ave, Hoboken, NJ 07030-3808 | |
| (201) 418-1600 | |
| Not Available |
| Full Name | Dr Robin Kyin |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 308 Willow Ave, Hoboken, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205094281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 25MA08581600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayonne Medical Center | Bayonne, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Progressive Hudson Anesthesia Llc | 2769615103 | 4 |
| Garden State Healthcare Associates Llc | 8426190687 | 149 |
News Archive
U.S. House of Representatives Minority Leader Nancy Pelosi (D-Calif.) on Wednesday announced the new top Democrats on House committees, Bloomberg reports.
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo
Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).
You've seen it in horror movies, or even in real-life at the local museum: a painting in which the eyes of the person portrayed seem to follow you around the room, no matter where you go.
Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.
› Verified 9 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
U.S. House of Representatives Minority Leader Nancy Pelosi (D-Calif.) on Wednesday announced the new top Democrats on House committees, Bloomberg reports.
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo
Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).
You've seen it in horror movies, or even in real-life at the local museum: a painting in which the eyes of the person portrayed seem to follow you around the room, no matter where you go.
Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.
› Verified 9 days ago
| Entity Name | Progressive Hudson Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477887446 PECOS PAC ID: 2769615103 Enrollment ID: O20140509000223 |
News Archive
U.S. House of Representatives Minority Leader Nancy Pelosi (D-Calif.) on Wednesday announced the new top Democrats on House committees, Bloomberg reports.
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo
Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).
You've seen it in horror movies, or even in real-life at the local museum: a painting in which the eyes of the person portrayed seem to follow you around the room, no matter where you go.
Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robin Kyin, MD 308 Willow Ave, Hoboken, NJ 07030-3808 Ph: (201) 418-1600 | Dr Robin Kyin, MD 308 Willow Ave, Hoboken, NJ 07030-3808 Ph: (201) 418-1600 |
News Archive
U.S. House of Representatives Minority Leader Nancy Pelosi (D-Calif.) on Wednesday announced the new top Democrats on House committees, Bloomberg reports.
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo
Ardea Biosciences, Inc. has announced positive results from a Phase 1 study in normal, healthy volunteers of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, and a pilot Phase 2a proof-of-concept study in gout patients of RDEA594's prodrug, RDEA806 (RDEA806 is converted to RDEA594 in the body).
You've seen it in horror movies, or even in real-life at the local museum: a painting in which the eyes of the person portrayed seem to follow you around the room, no matter where you go.
Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.
› Verified 9 days ago
Ramon Rafer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 308 Willow Ave, Hoboken, NJ 07030 Phone: 201-945-2481 Fax: 201-943-8105 | |
Maria Punzalan, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 308 Willow Ave, Hoboken, NJ 07030 Phone: 201-945-2481 Fax: 201-943-8105 | |
Dr. Susan Sisbarro, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1125 Maxwell Ln, #722, Hoboken, NJ 07030 Phone: 973-449-7655 | |
David Rocamboli, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1100 Adams St, Apt 509, Hoboken, NJ 07030 Phone: 917-873-6284 Fax: 973-893-0135 | |
Rodrigo T Largoza, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 308 Willow Ave, Hoboken, NJ 07030 Phone: 201-945-2481 Fax: 201-943-8105 | |
Sen-pin Kao, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 308 Willow Ave, Hoboken, NJ 07030 Phone: 201-945-2481 Fax: 201-943-8105 |